138 related articles for article (PubMed ID: 16797059)
1. Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation.
Jeon OH; Kim D; Choi YJ; Kim SH; Choi WS; Kim DS
Thromb Res; 2007; 119(5):609-19. PubMed ID: 16797059
[TBL] [Abstract][Full Text] [Related]
2. ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.
Langer H; May AE; Bültmann A; Gawaz M
Thromb Haemost; 2005 Sep; 94(3):555-61. PubMed ID: 16268472
[TBL] [Abstract][Full Text] [Related]
3. Integrin binding characteristics of the disintegrin-like domain of ADAM-15.
Lu D; Chung KF; Xia M; Lu X; Scully M; Kakkar V
Thromb Haemost; 2006 Nov; 96(5):642-51. PubMed ID: 17080222
[TBL] [Abstract][Full Text] [Related]
4. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (metargidin, ADAM-15) with integrin alphavbeta3.
Zhang XP; Kamata T; Yokoyama K; Puzon-McLaughlin W; Takada Y
J Biol Chem; 1998 Mar; 273(13):7345-50. PubMed ID: 9516430
[TBL] [Abstract][Full Text] [Related]
5. ADAM-15 disintegrin-like domain structure and function.
Lu D; Scully M; Kakkar V; Lu X
Toxins (Basel); 2010 Oct; 2(10):2411-27. PubMed ID: 22069559
[TBL] [Abstract][Full Text] [Related]
6. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes.
Lee HD; Koo BH; Kim YH; Jeon OH; Kim DS
FASEB J; 2012 Jul; 26(7):3084-95. PubMed ID: 22505472
[TBL] [Abstract][Full Text] [Related]
7. A novel disintegrin-like domain of a high molecular weight metalloprotease inhibits platelet aggregation.
You WK; Jang YJ; Chung KH; Kim DS
Biochem Biophys Res Commun; 2003 Sep; 309(3):637-42. PubMed ID: 12963038
[TBL] [Abstract][Full Text] [Related]
8. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions.
Eto K; Huet C; Tarui T; Kupriyanov S; Liu HZ; Puzon-McLaughlin W; Zhang XP; Sheppard D; Engvall E; Takada Y
J Biol Chem; 2002 May; 277(20):17804-10. PubMed ID: 11882657
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
[TBL] [Abstract][Full Text] [Related]
10. Identification of binding peptides of the ADAM15 disintegrin domain using phage display.
Wu J; Wu MC; Zhang LF; Lei JY; Feng L; Jin J
J Biosci; 2009 Jun; 34(2):213-20. PubMed ID: 19550037
[TBL] [Abstract][Full Text] [Related]
11. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion.
Beck V; Herold H; Benge A; Luber B; Hutzler P; Tschesche H; Kessler H; Schmitt M; Geppert HG; Reuning U
Int J Biochem Cell Biol; 2005 Mar; 37(3):590-603. PubMed ID: 15618016
[TBL] [Abstract][Full Text] [Related]
12. Integrin alphaIIbbeta3-specific synthetic human monoclonal antibodies and HCDR3 peptides that potently inhibit platelet aggregation.
Chung J; Rader C; Popkov M; Hur YM; Kim HK; Lee YJ; Barbas CF
FASEB J; 2004 Feb; 18(2):361-3. PubMed ID: 14688205
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins.
Reiss S; Sieber M; Oberle V; Wentzel A; Spangenberg P; Claus R; Kolmar H; Lösche W
Platelets; 2006 May; 17(3):153-7. PubMed ID: 16702041
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet aggregation of a mutant proinsulin chimera engineered by introduction of a native Lys-Gly-Asp-containing sequence.
Jing J; Lu S
Biotechnol Lett; 2005 Sep; 27(17):1259-65. PubMed ID: 16215822
[TBL] [Abstract][Full Text] [Related]
15. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J
Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15.
Lu D; Xie S; Sukkar MB; Lu X; Scully MF; Chung KF
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):494-500. PubMed ID: 17575078
[TBL] [Abstract][Full Text] [Related]
17. A novel role for the fibrinogen Asn-Gly-Arg (NGR) motif in platelet function.
Moriarty R; McManus CA; Lambert M; Tilley T; Devocelle M; Brennan M; Kerrigan SW; Cox D
Thromb Haemost; 2015 Feb; 113(2):290-304. PubMed ID: 25413489
[TBL] [Abstract][Full Text] [Related]
18. [Improving production and bioactivity of recombinant human disintegrin domain of ADAM15 (rhADAM15) in Escherichia coli].
Wu J; Lei J; Zhang L; Hua H; Jin J
Wei Sheng Wu Xue Bao; 2008 Aug; 48(8):1067-74. PubMed ID: 18956757
[TBL] [Abstract][Full Text] [Related]
19. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
Barre DE
Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
[TBL] [Abstract][Full Text] [Related]
20. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression.
Lucas N; Day ML
J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
